Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours
| Autor: | Awada, A., Eskens, F.A.L.M., Piccart, M., Cutler, D.L., van der Gaast, A., Bleiberg, H., Wanders, J., Faber, M.N., Statkevich, P., Fumoleau, P., Verweij, J. |
|---|---|
| Zdroj: | In European Journal of Cancer November 2002 38(17):2272-2278 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect